Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Antares Vision Share Issue/Capital Change 2022

Mar 2, 2022

4255_rns_2022-03-02_459d9b56-f89f-42ff-8db4-2bf439dcbb40.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

PRESS RELEASE

PROCEDURES AND EXERCISE RATIO OF ANTARES VISION WARRANTS

Travagliato (BS), 2 March 2022 - Antares Vision S.p.A. ("Antares Vision" or the "Company") announces that, pursuant to article 3 of the Regulation of "Antares Vision S.p.A. Warrants" (respectively, the "Warrants Regulation" 1 and the "Warrants"), the Average Monthly Price for February 2022 is Euro 9.6889 (source FactSet, Average Monthly Price calculated as the arithmetic average of the official prices of ordinary Antares Vision S.p.A. shares on stock market trading days in February).

Therefore, as the Strike Price is Euro 9.50 and the Subscription Price of the Conversion Shares is Euro 0.10, the Exercise Ratio for March 2022 is 0.0197.

Any request to exercise the Warrants must be submitted to the broker who is a member of the centralised management system of Monte Titoli S.p.A., where the Warrants are deposited, by the Last Trading Day of March 2022. The Company will make the relative Conversion Shares available for trading, through Monte Titoli S.p.A., on the settlement day following the end of March 2022. The conversion shares will have the same dividends as ordinary shares on the effective date of exercise of the Warrants.

The Subscription Price must be fully paid into the Company's current account indicated below at the time the exercise request is submitted:

IBAN SWIFT IT 59 V 05387 11236 000042573777 BPMOIT22XXX

In all cases in which at the time the Warrants are exercised, a fractional number of Conversion Shares is due, the Warrant holder will have the right to receive Conversion Shares up to the amount of the immediately lower whole number and will not have any right with regard to the fractional part in excess.

At the time the exercise request is submitted, the Warrant holder shall acknowledge that the Conversion Shares assigned under exercise of the Warrants have not been registered pursuant to the 1933 Securities Act, as amended, in force in the United States of America.

Antares Vision also announces that in January, exercise requests were received for a total of 2,004 Warrants. Consequently, the Company issued 354 ordinary shares, for a total counter value of Euro 35.40 (of which Euro 34.55 as share premium), in accordance with the procedures envisaged by the Warrants Regulation.

Following the exercise of the Antares Vision warrants, the new share capital of Antares Vision is Euro 169,452.91, divided into 69,119,526 ordinary shares, 250,000 Special Shares and 1,189,590 Performance Shares, with no nominal value indicated for any category.

For any further information, please refer to the Warrants Regulation available on the website of Antares Vision www.antaresvision.com - "Investors – Investor Relations – Warrant" section.

1 The terms indicated in this press release with a capital letter have the same meaning as those contained in the Warrants Regulation.

PRESS RELEASE

ABOUT ANTARES VISION GROUP

Antares Vision Group is an outstanding technology partner in digitalization and innovation for enterprises and institutions, guaranteeing the safety of products and people, business competitiveness and environmental protection.

Antares Vision Group is a technological enabler of supply chain transparency and of sustainable transition, to protect business competitiveness and the uniqueness of each country.

It provides a unique and comprehensive ecosystem of technologies to guarantee product quality (inspection systems and equipment) and end-to-end product traceability (from raw materials to production, from distribution to the consumer), with integrated data, production and supply chain management, also achieved through the application of artificial intelligence and the use of blockchains.

Antares Vision Group is active in the Life Science sector (pharmaceutical, biomedical devices and hospitals), in the beverage, food and cosmetics industries, and has potential in other sectors. The world leader in Track&Trace systems for pharmaceutical products, it provides the major global manufacturers (over 50% of the top 20 multinationals) and numerous government authorities with solutions to monitor their supply chains and validate product authenticity.

Listed since April 2019 on the Italian Stock Exchange in the AIM (Alternative Investment Market) segment, and from 14 May 2021 in the STAR segment of the MTA (Electronic equity market), Antares Vision Group recorded a turnover of Euro 162 million in 2020, operates in 60 countries, employs around 1000 people and has a consolidated network of over 40 international Partners.

Further information please visit www.antaresvision.com and www.antaresvisiongroup.com

For further information

ISSUER ANTARES VISION GROUP ALESSANDRO BAJ BADINO (HEAD OF INVESTOR RELATIONS) TEL.: +39 030 72 83 500 E-MAIL: [email protected]